Intervention Review

You have free access to this content

Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection

  1. Yun Xia1,2,
  2. Hui Luo1,
  3. Jian Ping Liu1,2,*,
  4. Christian Gluud2

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 30 APR 2013

Assessed as up-to-date: 5 DEC 2012

DOI: 10.1002/14651858.CD009004.pub2


How to Cite

Xia Y, Luo H, Liu JP, Gluud C. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD009004. DOI: 10.1002/14651858.CD009004.pub2.

Author Information

  1. 1

    Beijing University of Chinese Medicine, Centre for Evidence-Based Chinese Medicine, Beijing, China

  2. 2

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, The Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Jian Ping Liu, jianping_l@hotmail.com. jianping@fagmed.uit.no.

Publication History

  1. Publication Status: New
  2. Published Online: 30 APR 2013

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Douglas Thorburn, Brian R Davidson, Pharmacological treatments for chronic hepatitis B liver disease: a network meta-analysis, The Cochrane Library,